Court Rules for Baxter in Patent Infringment Case Over Abbott's Sevoflurane

Drug Industry Daily
KEYWORDS courts / generic / Patents

A judge in the U.S. District Court for the Northern District of Illinois has ruled that Baxter’s version of Abbott Laboratories’ anesthetic sevoflurane did not infringe on Abbott’s patent. The court also found, however, that Baxter did not invalidate Abbott’s patent.

To View This Article:


Subscribe To Drug Industry Daily